Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06415799 · ClinicalTrials.gov registry record

OM2 Abbreviated Sensor Verification

A clinical trial of Hypoxia, sponsored by Medtronic - MITG.

Completed
Registry status
28
Enrollment target
1
Study location

NCT06415799 is a study of Hypoxia that has completed, run by Medtronic - MITG. The registered enrollment target is 28 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06415799, a study of Hypoxia, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
28 participants
Enrollment target
1
Study location

Study Summary

The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

Conditions Studied

Study Locations (1)

Colorado

  • Element - Louisville

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2024-02-11
Est. Completion 2024-02-22

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT06415799

The ClinicalTrials.gov registry entry for NCT06415799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 0 interventions.

NCT06415799 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06415799 about?

NCT06415799 is a clinical study titled "OM2 Abbreviated Sensor Verification". The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

What is the current status of trial NCT06415799?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2024-02-11. Estimated completion is 2024-02-22.

What conditions does trial NCT06415799 study?

This clinical trial studies the following conditions: Hypoxia.

Who is sponsoring clinical trial NCT06415799?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06415799 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.